Introduction
============

Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM), which is a major health problem worldwide ([@b1-mmr-13-04-3017]). Chronic inflammation and oxidative stress are crucial contributors to the progression of DN ([@b2-mmr-13-04-3017]). Various preventable factors, including hypertension, alcoholism and smoking, also accelerate DN progression. Epidemiological studies suggest that cigarette smoking increases the progression rate of renal failure among insulin-and non-insulin-dependent patients with DM ([@b3-mmr-13-04-3017]), and is associated with elevated serum creatinine levels ([@b4-mmr-13-04-3017]). A dose-dependent relationship between the number of cigarettes smoked and the development of albuminuria was reported in type 1 DM ([@b5-mmr-13-04-3017]). Additionally, the prevalence of microalbuminuria and macroalbuminuria was significantly higher in patients with type 2 DM that were smokers. A possible role of smoking in the acceleration of renal remodeling and damage was postulated to operate via a mechanism independent of the damage caused by DM ([@b6-mmr-13-04-3017]). Evidence from the European population indicates that smoking may be associated with the progression of chronic kidney disease (CKD), particularly in men ([@b7-mmr-13-04-3017]).

Previous studies have focused on anti-inflammatory and anti-oxidative treatments as a method to delay the progression of glomerulopathy ([@b2-mmr-13-04-3017],[@b8-mmr-13-04-3017]). Curcumin, derived from the rhizome of the herb *Curcuma longa*, has been indicated to possess a variety of beneficial effects, including anti-inflammatory and anti-oxidative activities ([@b9-mmr-13-04-3017]). Curcumin has been demonstrated to be protective against nephropathy and islet damage in streptozotocin (STZ)-induced diabetic rats ([@b10-mmr-13-04-3017],[@b11-mmr-13-04-3017]). Curcumin was previously reported to be effective in preventing glucose-induced oxidative stress in the endothelial cells and hearts of diabetic animals ([@b12-mmr-13-04-3017]).

The current study aimed to investigate the potential protective effects of curcumin against the combined oxidative stress of DM and nicotine (NC), a major component of cigarette smoke.

Materials and methods
=====================

Animals
-------

A total of 24 adult male Wistar rats (65--70 days old, 190--220 g) were purchased from the Experimental Animal Center, Faculty of Pharmacy, King Saud University (Riyadh, Saudi Arabia). Animals were housed in the animal facility of the College of Science, Taif University (Taif, Saudi Arabia) at 22°C and 55% humidity with a 12 h light/dark cycle. The rats were fed a standard pellet diet and provided with water *ad libitum*. The present study was approved by the ethical committee of Taif University.

Reformation of animal food with the addition of curcumin
--------------------------------------------------------

As curcumin is water insoluble, it was added to the food of the animals at a concentration of 1.5 g/kg of food. The food pellet was crushed to a powder and mixed thoroughly with curcumin powder (Nature\'s Purest, West Los Angeles, CA, USA). A small volume of water was added to create a paste and the pellets were reformed. The pellets were left to air dry for 4 days. The concentration of curcumin was selected based on the average body weight of the rats (\~200 g) and the estimated average daily feed consumption (\~25--30 g/day). The NC (Merck Millipore, Darmstadt, Germany) concentration was also selected according to the average body weight and the average daily water consumption (\~25 ml/day).

Experimental design
-------------------

Following 1-week acclimatization, the rats were divided into 2 groups as follows: 18 rats were fasted for 8 hrs, after which they were injected intraperitonealy with a single dose of streptozotocin (STZ; 60 mg/kg body weight; Sigma-Aldrich, St. Louis, MO, USA) freshly dissolved in citrate buffer (pH 4.5); and a negative control group (6 rats) were injected with an equivalent volume of vehicle (citrate buffer, pH 4.5). Following injection, the rats were provided with free access to food and water, and were given a 5% glucose solution to drink overnight to counteract hypoglycemic shock. DM in the rats was identified by moderate polydipsia and marked polyuria. After 3 days, the fasting blood glucose levels were measured in tail blood samples (Accu-Chek Aviva Blood Glucose Meter; Roche Diagnostics, Indianapolis, IN, USA). The rats with glucose levels \>200 mg/100 ml were considered to be diabetic and selected for further experimentation. The diabetic rats were divided into three groups of six rats each as follows: i) The DM group; ii) the DM + NC group; and iii) the DM + NC + curcumin group. NC was added to the drinking water of the DM + NC and the DM + NC + curcumin group rats at a concentration of 12 *µ*g/ml to attain a treatment dose of 1.5 mg/kg body weight. The food of the DM + NC + curcumin group rats was additionally supplemented with curcumin at a concentration of 1.5 g/kg body weight to obtain a final concentration of 1.5 mg/kg body weight. Treatments were continued for the 8 weeks following induction of DM. Random blood glucose levels were measured from tail blood samples every week to ensure the rats remained diabetic. At the end of the experiment, the rats were fasted for 8 h and anesthetized with diethyl ether (≥99.0%; Sigma-Aldrich), while blood samples were taken from the medial canthus of the eyes into heparinized tubes. The rats were sacrificed by head dislocation and tissue samples were taken for RNA extraction and stored at −80°C prior to use. Samples for histological examination were stored in 10% formalin (Sigma-Aldrich) until processing.

Biochemical analysis
--------------------

Urea and plasma creatinine assays were performed using the UREA liquicolor (cat. no. 10505) and CREATININE liquicolor (cat. no. 10051) Complete Test kits purchased from HUMAN Gesellschaft für Biochemica und Diagnostica mbH (Wiesbaden, Germany). Cholesterol, triacylglycerol (TG) and high density lipoprotein (HDL) levels were measured using kits (cat. nos. 024-100, 059L-050 and 041-050, respectively) purchased from United Diagnostics Industry (Dammam, Saudi Arabia). Commercial kits were purchased from Nanjing Jiancheng Bioengineering Research Institute (Nanjing, China) to measure the levels of plasma malondialdehyde (MDA; A003-1), and the activities of γ-glutamyltranspeptidase (GGT), superoxide dismutase (SOD; A001-1) and glutathione peroxidase (GPx; A005). The plasma phospholipid levels were determined using the Phospholipid Assay kit (MAK122; Sigma-Aldrich), according to the manufacturer\'s protocol. The concentrations of the measured biochemical constituents were calculated according to the manufacturer\'s instructions.

RNA extraction
--------------

For preparation of total RNA, 50 mg of kidney tissue sample was homogenized in 1 ml QIAzol (Qiagen, Inc., Valencia, CA, USA) and 0.3 ml chloroform (Nanjing Jiancheng Bioengineering Research Institute) was added to the homogenate. The mixtures were then shaken for 30 sec followed by centrifugation at 4°C and 12,000 × g for 20 min. The supernatant layers were transferred to a new set of tubes, and an equal volume of isopropanol (Sigma-Aldrich) was added to the samples. The samples were shaken for 15 sec and centrifuged at 4°C and 12,000 x g for 15 min. The RNA pellets were washed with 70% ethanol, briefly dried and dissolved in diethylpyrocarbonate (DEPC) water. The prepared RNA integrity was determined by 1.5% agarose gel electrophoresis. The RNA concentration and purity were determined spectrophotometrically at 260 nm using the GelDoc-It Imaging System (UVP, Inc., Upland, CA, USA). The ratio of the 260/280 nm optical density of all RNA samples was 1.7--1.9.

cDNA synthesis
--------------

DNase treatment of the extracted RNA was performed prior to cDNA synthesis using the RQ1 RNase-Free DNase kit (M6101; Promega Corporation, Madison, WI, USA). For synthesis of cDNA, a mixture of 2 *µ*g total RNA and 0.5 ng Oligo (dT)15 primers (Macrogen, Inc., Seoul, Korea) in a total volume of 11 *µ*l sterilized DEPC water was incubated in the Thermo Hybaid PXE 0.2 Thermal Cycler (Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 70°C for 10 min for denaturing. Subsequently, 4 *µ*l 5X RT-buffer, 2 *µ*l 10 mM dNTPs and 100 units RevertAid Premium reverse transcriptase (Fermentas; Thermo Fisher Scientific, Inc., Pittsburgh, PA, USA) were added to the reaction mixture and DEPC water was used to bring the total volume to 20 *µ*l. The mixture was then incubated in the thermal cycler at 30°C for 10 min, 42°C for 1 h and 90°C for 10 min. The resulting cDNA was then preserved at −20°C until use.

Semi-quantitative polymerase chain reaction (PCR)
-------------------------------------------------

The mRNA expression levels of gene markers of kidney damage, kidney protection and integrity, and inflammation and fibrosis were analyzed by semi-quantitative PCR using the corresponding gene-specific primers ([Table I](#tI-mmr-13-04-3017){ref-type="table"}). The genes analyzed were vimentin, desmin, synaptopodin (SPD), connexin 43 (Cx43), sterol regulatory element-binding protein-1c (SREBP-1c), transforming growth factor β1 (TGF-β1) and erythropoietin (EPO). As a reference gene, the expression of GAPDH mRNA was determined. The primers were designed using the Oligo Primer Analysis software, version 4 ([www.oligo.net](http://www.oligo.net)) and nucleotide sequences published in Genbank ([www.ncbi.nlm.nih.gov/genbank](http://www.ncbi.nlm.nih.gov/genbank); [Table I](#tI-mmr-13-04-3017){ref-type="table"}). The primers were synthesized by Macrogen, Inc. PCR was conducted in a final reaction volume of 25 *µ*l consisting of 1 *µ*l cDNA, 1 *µ*l of each 10 pM forward and reverse primers, 12.5 *µ*l PCR master mix (Promega Corporation) and nuclease-free deionized water. PCR was conducted using the thermal cycler with a cycle sequence of denaturing at 94°C for 4 min for 1 cycle, followed by 25--32 cycles of denaturation at 94°C for 1 min, annealing at the specific temperature corresponding to each primer (see [Table I](#tI-mmr-13-04-3017){ref-type="table"}) and extension at 72°C for 1 min, with an additional final extension step at 72°C for 5 min. A pilot study was performed to optimize the specific number of cycles for each gene according to its expression level. The PCR products were electrophoresed on a 1% agarose A (Bio Basic Canada, Inc., Markham, ON, Canada) gel in Tris-EDTA buffer at 100 V for 30 min, and stained with ethidium bromide. The PCR products were visualized under UV light and images were captured using the GelDoc-It Imaging System. The intensities of the bands were densitometrically quantified using NIH Image software (National Institutes of Health, Bethesda, MD, USA; [rsb.info.nih.gov/nih-image](http://rsb.info.nih.gov/nih-image)).

Histological examination
------------------------

Small specimens (1.5×0.5 cm) from the pancreas and kidneys were fixed in 10% neutral-buffered formalin (Sigma-Aldrich) for 24 h, then washed under a running tap and preserved in 70% ethanol. The samples were dehydrated in ascending grades of ethanol, cleared in xylene (Sigma-Aldrich), embedded in Paraplast Plus (Sigma-Aldrich) and sectioned to 5 *µ*m thickness. Tissue sections were mounted onto positively charged, coated slides (Thermo Fisher Scientific, Inc.). Sections were stained with hematoxylin and eosin (Sigma-Aldrich) for studying the general histological analyses ([@b13-mmr-13-04-3017]).

Immunohistochemistry
--------------------

For immunohistochemical detection of insulin granules, paraffin-embedded sections of the pancreas were deparaffinized in xylene, rehydrated in descending grades of alcohol and then immersed in 0.3% hydrogen peroxide (Sigma-Aldrich) for 30 min to inactivate endogenous peroxidase activity. The samples were heated in 10 mM citrate buffer (Sigma-Aldrich) at 121°C for 30 min for antigen retrieval, blocked in 5% normal serum (Sigma-Aldrich) for 20 min, and incubated with a rabbit polyclonal anti-insulin \[dilution, 1:100 in phosphate-buffered saline (PBS); sc-9168; Santa Cruz Biotechnology Inc., Dallas, TX, USA\] antibody overnight at 4°C. Subsequently, three PBS washes were performed and the sections were incubated with a goat anti-rabbit biotin-conjugated secondary antibody (dilution, 1:2,000 in PBS; sc-2040; Santa Cruz Biotechnology, Inc.) for 20 min at room temperature. After further incubation with horseradish peroxidase-labeled streptavidin (Vector Laboratories, Inc., Burlingame, CA, USA), the antibody binding was visualized with diaminobenzidine (Sigma-Aldrich) and sections were counterstained with hematoxylin. Negative controls, in which the primary or secondary antibodies, or the avidin-biotin complex reagent was omitted, produced no positive staining. Positive controls were used according to the instructions provided by the manufacturer\'s of the primary antibodies.

Photomicrography
----------------

Photomicrographs were captured using a Leica DM LB light microscope (Leica Microsystems, Inc., Buffalo Grove, IL, USA) and a Leica EC3 digital camera (Leica Microsystems, Inc.).

Statistic analysis
------------------

Statistical analysis was performed using analysis of variance and Scheffe\'s protected least-significant difference test on SPSS software, version 13.0 (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference. Results are expressed as the mean ± standard error.

Results
=======

Effect of curcumin on the plasma levels of biochemical parameters in diabetic rats
----------------------------------------------------------------------------------

In the present study, plasma levels of the anti-oxidant enzymes, SOD and GPx, were significantly decreased in diabetic rats compared with controls ([Table II](#tII-mmr-13-04-3017){ref-type="table"}), which may be caused by oxidative stress generated by the development of DM. Further reduction of these anti-oxidant enzyme levels was observed in diabetic rats treated with NC, however, the levels were increased to a level similar to that of the control by curcumin supplementation ([Table II](#tII-mmr-13-04-3017){ref-type="table"}). The plasma concentrations of the oxidative markers, MDA and γ-glutamyltranspeptidase (GGT), and the lipid profile, including cholesterol, TG and phospholipids, were increased in diabetic rats compared with control rats. This increase was enhanced by NC treatment. Curcumin supplementation reversed these effects of DM and NC. The diabetic nephropathy markers, urea and creatinine, were increased in rats of the diabetic group compared with levels in the control group. These were further enhanced in the DM + NC group, while almost normalized with curcumin supplementation.

Effect of curcumin on the mRNA expression of gene markers of kidney damage
--------------------------------------------------------------------------

Diabetic rats demonstrated upregulation of vimentin and desmin mRNA expression levels compared with control rats (P\<0.05; [Fig. 1](#f1-mmr-13-04-3017){ref-type="fig"}). Treatment of diabetic rats with NC decreased the expression levels of these genes compared with untreated diabetic rats (P\<0.05), however, the expression remained increased compared with the control group (P\<0.05). Following curcumin treatment, the DM and NC-induced upregulation of vimentin and desmin mRNA expression levels were comparable to the control group ([Fig. 1](#f1-mmr-13-04-3017){ref-type="fig"}).

Effect of curcumin on the mRNA expression of gap junction and podocytes integrity gene markers
----------------------------------------------------------------------------------------------

Diabetic rats demonstrated no changes to SPD mRNA expression level. However, diabetic rats treated with NC exhibited significantly reduced SPD mRNA expression levels compared with diabetic or control rats (P\<0.05; [Fig. 2A](#f2-mmr-13-04-3017){ref-type="fig"}). Diabetic rats treated with NC and curcumin exhibited increased levels of SPD mRNA expression compared with the diabetic rats with NC treatment (P\<0.05; [Fig. 2A](#f2-mmr-13-04-3017){ref-type="fig"}).

DM significantly decreased the Cx43 mRNA expression compared with the control levels (P\<0.05; [Fig. 2B](#f2-mmr-13-04-3017){ref-type="fig"}). Administration of NC to DM rats resulted in a further reduction of the Cx43 mRNA expression level. However, curcumin supplementation abrogated the combined inhibitory effect of DM and NC on the Cx43 mRNA, restoring its expression, as compared with the DM + NC group (P\<0.05; [Fig. 2B](#f2-mmr-13-04-3017){ref-type="fig"}).

Diabetic rats exhibited a downregulation of EPO mRNA expression levels compared with the control rats (P\<0.05; [Fig. 2C](#f2-mmr-13-04-3017){ref-type="fig"}). NC treatment of diabetic rats caused further suppression of EPO mRNA expression compared with the diabetic group (P\<0.05). Curcumin supplementation prevented the diabetic and NC-induced suppression of EPO (P\<0.05) and further increased EPO expression levels compared with control levels (P\<0.05; [Fig. 2C](#f2-mmr-13-04-3017){ref-type="fig"}).

Effect of curcumin on mRNA expression of kidney oxidative stress markers
------------------------------------------------------------------------

Diabetic rats exhibited upregulated SREBP-1c mRNA expression levels compared with control rats (P\<0.05; [Fig. 3A](#f3-mmr-13-04-3017){ref-type="fig"}). NC treatment of diabetic rats did not demonstrate any significant change to the SREBP-1c mRNA expression compared with diabetic rats. However, the DM-induced SREBP-1c mRNA expression was abolished by curcumin supplementation, as compared with the DM + NC group (P\<0.05; [Fig. 3A](#f3-mmr-13-04-3017){ref-type="fig"}).

Diabetic rats exhibited a significant increase of TGF-β1 mRNA expression levels compared with the control group (P\<0.05; [Fig. 3B](#f3-mmr-13-04-3017){ref-type="fig"}). NC treatment of diabetic rats decreased TGF-β1 mRNA expression levels compared with diabetic rats, however, the levels remained significantly higher compared with the control rats (P\<0.05). The DM-induced increases in the TGF-β1 mRNA expression level was significantly inhibited by curcumin supplementation, as compared with the DM + NC group (P\<0.05), and was normalized to control levels ([Fig. 3B](#f3-mmr-13-04-3017){ref-type="fig"}).

Diabetic rats exhibited upregulated iNOS mRNA expression levels compared with control rats. NC treatment of diabetic rats further increased iNOS mRNA expression levels, as compared with diabetic rats. However, the increased level of iNOS mRNA was inhibited by curcumin supplementation, compared with the DM and NC group (P\<0.05; [Fig. 3C](#f3-mmr-13-04-3017){ref-type="fig"}).

Histopathological findings
--------------------------

The effect of curcumin on the histological structure of the pancreas was investigated. Pancreatic sections from control rats exhibited islets of Langerhans cells, and contained lightly stained acidophilic cells arranged in branching and anastomosing cords ([Fig. 4A](#f4-mmr-13-04-3017){ref-type="fig"}). Sections immunostained for the presence of insulin displayed positive β-cells within the islets ([Fig. 4A](#f4-mmr-13-04-3017){ref-type="fig"}). Sections from diabetic rats displayed damaged islets, represented by cytoplasmic vacuolations, pyknotic nuclei and a decrease in insulin antibody reaction ([Fig. 4B](#f4-mmr-13-04-3017){ref-type="fig"}). β-Cells from diabetic rats that received NC exhibited more severe islet alterations ([Fig. 4C](#f4-mmr-13-04-3017){ref-type="fig"}). Sections from diabetic rats that received NC and curcumin exhibited decreased β-cell damage and increased numbers of positive insulin-reacted cells ([Fig. 4D](#f4-mmr-13-04-3017){ref-type="fig"}).

Effect of curcumin on the kidney histological structure
-------------------------------------------------------

Kidney sections of control rats displayed the cortex to be occupied by renal corpuscles and surrounding proximal and distal convoluted tubules ([Fig. 5A](#f5-mmr-13-04-3017){ref-type="fig"}, left panel), and the medulla tissue exhibited straight proximal and distal tubules, collecting ducts and thin tubules distinguished from medullary blood capillaries ([Fig. 5A](#f5-mmr-13-04-3017){ref-type="fig"}, right panel). Kidney tissues from DM rats displayed tissue damage, including glomerular hypertrophy, hypercellularity, mesangial expansion, pronounced glomerular sclerosis, severe tubulo-interstitial changes represented by lipid accumulation in the cortical tubules, tubular dilatation, interstitial mononuclear cell infiltration and fibroplasia ([Fig. 5B](#f5-mmr-13-04-3017){ref-type="fig"}). NC treatment further enhanced tissue damage, which was represented by increases in glomerular hypertrophy, sclerosis, mesangial expansion and severe tubulo-interstitial changes ([Fig. 5C](#f5-mmr-13-04-3017){ref-type="fig"}). However, curcumin treatment reduced the incidence of glomerular sclerosis, lipid accumulation and tubular dilatation compared with that of diabetic rats receiving NC without curcumin treatment ([Fig. 5D](#f5-mmr-13-04-3017){ref-type="fig"}).

Discussion
==========

The results of the present study demonstrated vimentin and desmin mRNA levels to be upregulated in diabetic rats. This indicates tissue injury, as vimentin is an important marker of tubular epithelial-mesenchymal transition (EMT) ([@b14-mmr-13-04-3017]). Desmin upregulation is considered to be a marker of podocyte injury ([@b15-mmr-13-04-3017]). The downregulation of vimentin and desmin in diabetic rats by NC indicated that NC-induced DN exaggeration may require vimentin and desmin upregulation. However, their normalization following curcumin supplementation suggested that curcumin protects against DN. The results of the current study are in agreement with a previous finding demonstrating that fasudil (a renal anti-fibrotic drug) prevented high glucose-induced EMT via decreased vimentin expression ([@b16-mmr-13-04-3017]).

The slit diaphragm is important in the prevention of glomerular protein leakage during physiological and pathological processes ([@b17-mmr-13-04-3017]). The slit diaphragm consists of proteins specifically expressed by podocytes, including nephrin, podocin, and SPD ([@b18-mmr-13-04-3017]). The observation of reduced expression of SPD and Cx43 mRNA levels in diabetic rats in the present study corroborates previous studies that have demonstrated Cx43 reduction in the kidneys of STZ-diabetic rats ([@b19-mmr-13-04-3017]) and reduced SPD expression in the glomeruli of patients with DM ([@b20-mmr-13-04-3017]). The further downregulation of SPD and Cx43 mRNA levels by NC exposure implies that the NC-induced progression of DN may act via gap junctions and perturbation of podocytes. The reduction of SPD mRNA expression levels in diabetic rats may indicate the loss of podocytes in the urine, and its further reduction in diabetic rats treated with NC may indicate that NC increases the loss of podocytes in urine. Previous studies have demonstrated increased gene expression levels of podocyte markers, including SPD, in the urine of patients with DN, implying increased excretion of podocytes ([@b21-mmr-13-04-3017]). The prevention of the suppressive effect of DM and NC on SPD and Cx43 mRNA levels by curcumin indicates that curcumin may protect podocytes and renal gap junctions against the oxidative stress caused by DM and smoking.

The downregulation of EPO mRNA expression levels in diabetic rats may be associated with the high risk of anemia, as patients with DN have a greater risk of developing anemia ([@b22-mmr-13-04-3017]). DM-associated events in DN, such as tubulo-interstitial damage, result in the impairment of EPO production by peritubular fibroblasts, leading to the development of anemia ([@b23-mmr-13-04-3017]). In the present study, the further suppression of EPO mRNA levels in diabetic rats exposed to NC indicated the ability of NC to increase cumulative oxidative stress and suppress EPO. Smoking during pregnancy was previously reported to be associated with a high risk of compromised child development due to maternal anemia and fetal hypoxia ([@b24-mmr-13-04-3017]). Curcumin protected EPO mRNA expression levels from the combined inhibition by DM and NC, indicating that curcumin may be able to protect the kidney from anemia caused by DM and NC. A previous study suggested that EPO administration may reduce anemia and slow the progression of CKD ([@b25-mmr-13-04-3017]). EPO upregulation by curcumin in the current study may also represent a pathway via which curcumin mediates its reported protective activity against obesity-induced oxidative stress in mice ([@b26-mmr-13-04-3017]).

Renal SREBP-1c upregulation is an important mechanism leading to renal TG accumulation and DN ([@b27-mmr-13-04-3017]). In the current study, SREBP-1c mRNA upregulation was indicated, consistent with trends observed in previous studies on mesangial cells ([@b28-mmr-13-04-3017]) and rats with type 1 DM ([@b29-mmr-13-04-3017]). TGF-β1 is considered as one of the main cytokines that aggravates DN ([@b30-mmr-13-04-3017]). ECM accumulation is one of the characteristic structural abnormalities associated with DN, in addition to kidney hypertrophy and increased thickness of the glomerular basement membrane ([@b31-mmr-13-04-3017]). In the present study, the upregulation TGF-β1 in diabetic rats may be caused by SREBP-1c activation. Previously, high glucose-induced TGF-β1 upregulation was demonstrated to be caused by the binding of activated SREBP-1c to the TGF promoter ([@b28-mmr-13-04-3017]). In the current study, the partial downregulation of TGF-β1 caused by NC in DM rats may indicate that NC is able to partially inactivate the SREBP-1c protein, as the mRNA expression level of SREBP-1c was not affected. NC was previously demonstrated to improve the serum lipid profile, decrease insulin serum levels, and to reduce steatosis and inflammation ([@b32-mmr-13-04-3017]). The normalization of the SREBP-1 mRNA expression levels by curcumin supplementation in diabetic rats may be important for the normalization of TGF-β1 and may represent a pathway by which curcumin protects the kidney from DN. Zhenqing recipe (a Chinese herbal prescription for improvement of renal function) has been reported to improve DN through the downregulation of SREBP-1c mRNA, which is overexpressed in rats with type 2 DM ([@b33-mmr-13-04-3017]). Additionally, TEMPOL (a SOD-mimicking drug) was reported to ameliorate the pathological changes in diabetic glomeruli by reducing the TGF-β1 expression levels ([@b34-mmr-13-04-3017]). The results of the current study indicated that NC has 2 opposing effects on the kidney as follows: A protective effect represented by the downregulation of vimentin and desmin expression; and a detrimental effect represented by the downregulation of SPD, Cx43 and EPO and the upregulation of iNOS mRNA expression levels. However, the net effects of NC on the kidney demonstrate an increase in the markers of kidney function (creatinine, urea and MDA), further reductions in the levels of GPx and SOD in the serum, and the histopathological changes to the kidney structure. These changes demonstrate the overwhelmingly destructive effects of NC. Notably, destructive effects of combined DM and NC were ameliorated by curcumin supplementation.

The morphological changes in pancreatic islets from STZ-induced diabetic rats, including cytoplasmic vacuolations, pyknotic nuclei and the decrease in insulin-positive granules, are in agreement with previous reports ([@b35-mmr-13-04-3017]). STZ-induced DM is caused by oxidative stress on β-cells, which are particularly susceptible to oxidative insult due to their relatively low levels of antioxidants ([@b36-mmr-13-04-3017]). NC-induced oxidative stress ([@b37-mmr-13-04-3017]) increases the insult on the cells and may cause NC-induced β-cell apoptosis and permanent β-cell loss ([@b38-mmr-13-04-3017],[@b39-mmr-13-04-3017]). Abnormal lipid deposits have been previously reported in the renal cortical tubules of patients with DM ([@b40-mmr-13-04-3017]) and have been proposed to participate in the pathogenesis of DN in STZ-induced diabetic rats ([@b41-mmr-13-04-3017]). Curcumin amelioration of Langerhans lesions in rat pancreatic islets may be due to the anti-oxidative activity of curcumin, which may be mediated by decreased iNOS and/or increased EPO expression levels. Additionally, curcumin may exert its anti-oxidative effect via increased ROS scavenging activity through the upregulation of SOD and GPx mRNA levels. The infiltration of macrophages and mesangial accumulation of ECM proteins are commonly associated with DN ([@b42-mmr-13-04-3017]). In a previous study, curcumin exhibited renoprotective effects in STZ-induced type 1 DN, it reduced the proteinuria and pathological changes associated with DM through the inhibition of macrophage infiltration. Curcumin was suggested to have antifibrotic and anti-inflammatory effects ([@b43-mmr-13-04-3017]).

Increased lipid deposition in the kidney tubules of diabetic rats indicated disturbance in lipid metabolism caused by oxidative stress ([@b44-mmr-13-04-3017]). Additional lipid deposition due to NC exposure indicated that NC increases oxidative stress further in DM. The increased lipid deposition in the kidney contributes to cellular damage and to the progression of DN ([@b41-mmr-13-04-3017]). The ameliorative effect of curcumin against DM and the effects of NC may be due to its effects on a wide range of molecular targets that control lipid accumulation ([@b45-mmr-13-04-3017]). Curcumin was reported to protect against DN progression through the phosphorylation of AMP-activated kinase and SREBP-1c suppression, and the reduction of renal TG accumulation ([@b41-mmr-13-04-3017]).

In conclusion, the current study investigated the mechanisms through which curcumin protects against the combined oxidative stress of DM and NC exposure. Curcumin acts through normalizing the expression levels of various factors important during DN progression. This includes normalization of the levels of the suppressed antioxidants, SPD, Cx43 and EPO, and the DM-induced factors, MDA, GGT, vimintin, desmin, SREBP-1c, TGF-β1 and iNOS. Clarification of the underlying mechanisms of curcumin activity may provide novel therapeutic targets for the treatment of DN.
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![Effect of curcumin on diabetes-induced vimentin and desmin mRNA expression levels in kidney tissue. Total RNA was prepared from kidney tissues and the expression levels of (A) vimentin and (B) desmin were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. Values are presented as the mean ± standard error of 6 rats. ^\*^P\<0.05 vs. cont group; ^\$^P\<0.05 vs. DM group; ^\#^P\<0.05 vs. DM + NC group. Cont, control; DM, diabetes mellitus; NC, nicotine; Cr, curcumin.](MMR-13-04-3017-g00){#f1-mmr-13-04-3017}

![Effect of curcumin on mRNA expression of gene markers of gap junctions and podocyte integrity in kidney tissue. Total RNA was prepared from kidney tissues and the expression levels of (A) SPD (B) Cx43 and (C) EPO were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. Values are presented as the mean ± standard error of 6 rats. ^\*^P\<0.05 vs. cont group; ^§^P\<0.05 vs. DM group; ^\#^P\<0.05 vs. DM + NC group. SPD, synaptopodin; Cx43, connexin 43; EPO, erythropoietin; cont, control group; DM, diabetes mellitus; NC, nicotine; Cr, curcumin.](MMR-13-04-3017-g01){#f2-mmr-13-04-3017}

![Effect of curcumin on mRNA expression of gene markers of kidney oxidative stress. Total RNA was prepared from kidney tissues and the expression levels of (A) SREBP-1c, (B) TGF-β1 and (C) iNOS were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. Values are presented as the mean ± standard error of 6 rats. ^\*^P\<0.05 vs. cont group; ^\#^P\<0.05 vs. DM + NC group. SREPB-1c, sterol regulatory element binding protein 1; TGF-β1, transforming growth factor-β1; iNOS, nitric oxide synthase; Cont, control group; DM, diabetes mellitus; NC, nicotine; Cr, curcumin.](MMR-13-04-3017-g02){#f3-mmr-13-04-3017}

![Effect of curcumin on pancreas histological structure. Representative images from HE and insulin immunostained sections from (A) control rats, (B) DM rats, (C) DM + NC rats and (D) DM + NC + Cr rats. Pancreatic islets (asterisks) and β-cells (arrows) reveal cytoplasmic vacuolations or nuclear pyknosis (arrowheads) in diabetic rats. Scale bar = 15 *µ*m. HE, hematoxylin and eosin; cont, control group; DM, diabetes mellitus; NC, nicotine; Cr, curcumin.](MMR-13-04-3017-g03){#f4-mmr-13-04-3017}

![Effect of curcumin on the histological structure of the cortex (left panel) and medulla (right panel) of the rat kidneys (hematoxylin and eosin staining). (A) The cortex of the control rats had RC and proximal (arrowheads) and distal (arrow) convoluted tubules, and the medulla had a normal structure with thin tubules (arrows) and collecting ducts (arrowheads). (B) The cortex of the DM rats had enlarged RC, with glomerular sclerosis (arrowheads) and expansion (asterisk), and tubular lipid deposition (arrows) and dilatation. The medulla exhibited tubular dilatation, lipid deposition (arrows), interstitial nodular sclerosis and fibroplasia (asterisk). (C) The cortex from DM + NC rats had enlarged RC, with glomerular sclerosis and expansion (arrowheads), tubular lipid deposition (arrows) and pyknosis of a number of tubular cells (long-head arrow), and interstitial leukocytic infiltration (asterisk); the medulla exhibited tubular lipid deposition (arrows) and pronounced interstitial nodular sclerosis and fibroplasia (asterisks). (D) The cortex from DM + NC + Cr rats exhibited normal sized RC and a lower incidence of tubular lipid deposition (arrows), and the medulla displayed a normal histological structure of thin tubules (arrows) and collecting ducts (arrowheads). Scale bar = 30 *µ*m. RC, renal corpuscles; DM, diabetes mel-litus; NC, nicotine; Cr, curcumin.](MMR-13-04-3017-g04){#f5-mmr-13-04-3017}

###### 

Primers and polymerase chain reaction conditions used for the tested genes.

  Gene             Product size (bp)   Annealing temperature (°C)   Cycles   Primer      Sequence (5′-3′)
  ---------------- ------------------- ---------------------------- -------- ----------- ----------------------------
  GAPDH            309                 52                           25       Sense       AGATCCACAACGGATACATT
                                                                             Antisense   TCCCTCAAGATTGTCAGCAA
  Vimentin         190                 55                           30       Sense       GAGTCAAACGAATACCGGAGAC
                                                                             Antisense   GTGGTGCTGAGAAGTCTCATTG
  Desmin           420                 54                           28       Sense       TCACAATCACCTCTTTGTGGTC
                                                                             Antisense   CAGCACCTTCCAGTTCTCTCTT
  Synaptopodin     457                 59                           32       Sense       ACGCCCACTAAGGTGTATAGTGA
                                                                             Antisense   CTTCCAAAATTCCTGTCTTGTTG
  Connexin 43      435                 59                           30       Sense       TACTTGGCCCATGTGTTCTATG
                                                                             Antisense   AACGCCTTTGAAGAAGACGTAG
  SREBP-1c         191                 58                           28       Sense       GGAGCCATGGATTGCACATT
                                                                             Antisense   AGGAAGGCTTCCAGAGAGGA
  TGF-β1           304                 58                           30       Sense       TGAGTGGCTGTCTTTTGACG
                                                                             Antisense   TGGTTGTAGAGGGCAAGGAC
  Erythropoietin   530                 60                           29       Sense       TACGTAGCCTCACTTCACTGCTT
                                                                             Antisense   GCAGAAAGTATCCGCTGTGAGTGTTC
  iNOS             378                 59                           32       Sense       GGTGTTCTTTGCTTCTGTGCTA
                                                                             Antisense   TGAGACAGTTTCTGGTCGATGT

SREBP-1c, sterol regulatory element binding protein 1; TGF-β1, transforming growth factor β1; iNOS, inducible nitric oxide synthase.

###### 

Serum biochemical analysis.

  Parameter                          Control       DM                                                           DM + NC                                                                                                     DM + NC + Cr
  ---------------------------------- ------------- ------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------- ------------------------------------------------------------
  Glucose (mg/dl)                    101.00±0.70   479.30±50.00[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}   416.00±49.50[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}                                                  483.30±47.10[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}
  Superoxide dismutase (U/ml)        11.67±0.16    7.94±0.17[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}      5.80±2.00[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}      10.73±0.30[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Glutathione peroxidase (U/ml)      115.67±3.80   85.67±3.30[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     69.00±0.71[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}     105.30±9.40[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Malondialdehyde (nmol/ml)          3.00±0.80     4.40±2.10                                                    8.74±1.20[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}                                                     3.63±0.16[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  γ-Glutamyltranspeptidase (U/l)     4.91±0.50     7.53±0.41[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}      10.50±0.71[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}     6.10±1.10[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Cholesterol (mg/dl)                72.30±2.59    95.30±0.47[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     114.00±0.71[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}    79.70±0.94[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Triacylglycerol (mg/dl)            52.30±8.00    63.30±12.50                                                  81.70±4.50[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}     61.70±14.00[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  High density lipoprotein (mg/dl)   18.70±1.20    15.30±0.50[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     11.30±1.20[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}     21.00±1.01[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Phospholipid (mg/dl)               91.00±2.80    94.70±3.80                                                   122.30±4.00[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}    92.70±12.90[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Urea (mg/dl)                       68.30±9.33    95.00±4.95[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     138.00±24.75[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}   85.33±21.50[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}
  Creatinine (mg/dl)                 1.09±0.07     2.30±0.061[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     2.88±0.18[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"},[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}      1.60±0.23[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}
  Nitric oxide (*µ*mol/l)            22.70±1.70    62.00±4.70[a](#tfn3-mmr-13-04-3017){ref-type="table-fn"}     39.00±0.70[b](#tfn4-mmr-13-04-3017){ref-type="table-fn"}                                                    28.70±0.30[c](#tfn5-mmr-13-04-3017){ref-type="table-fn"}

Values are presented as the mean ± standard error (n=8).

P\<0.05 vs. the control group;

P\<0.05 vs. the DM group;

P\<0.05 vs. the DM + NC group. DM, diabetes mellitus; NC, nicotine; Cr, curcumin.
